Claims Analysis
Total Claims: 11
Claim 1
Independent Claim
465 words
A compound having the structure ##STR30## or a pharmaceutically acceptable salt thereof wherein A is a valence bond or is a straight or branched divalent alkylene group of from one to twelve carbon atoms; M is selected from the group consisting of hydrogen, a pharmaceutically acceptable cation, and a pharmaceutically acceptable metabolically cleavable group; R 1 is selected from the group consisting of phenoxy, optionally substituted with alkyl of from one to six carbon atoms, haloalkyl of from one to six carbon atoms, alkoxy of from one to six carbon atoms, hydroxy or halogen; phenyl-thio, optionally substituted with alkyl of from one to six carbon atoms, haloalkyl of from one to six carbon atoms, alkoxy of from one to six carbon atoms, hydroxy or halogen; 2-,3-, or 4-pyridyloxy, optionally substituted with alkyl of from one to six carbon atoms, haloalkyl of from one to six carbon atoms, alkoxy of from one to six carbon atoms, hydroxy or halogen; 2-,3-, or 4-pyridylmethoxy, optionally substituted with alkyl of from one to six carbon atoms, haloalkyl of from one to six carbon atoms, alkoxy of from one to six carbon atoms, hydroxy or halogen; 1, or 2-naphthyloxy, optionally substituted with alkyl of from one to six carbon atoms, haloalkyl of from one to six carbon atoms, alkoxy of from one to six carbon atoms, hydroxy or halogen; 2-,4-,5-, or 8-quinolyloxy, optionally substituted with alkyl of from one to six carbon atoms, haloalkyl of from one to six carbon atoms, alkoxy of from one to six carbon atoms, hydroxy or halogen; and 2-,4-,5-, or 8-quinolylmethoxy, optionally substituted with alkyl of from one to six carbon atoms, haloalkyl of from one to six carbon atoms, alkoxy of from one to six carbon atoms, hydroxy or halogen; R 2 and R 3 are independently selected from the group consisting of hydrogen, alkyl of from one to twelve carbon atoms, halogen, and trifluoroalkyl; R 4 is selected from the group consisting of hydrogen, alkyl of from one to twelve carbon atoms, cycloalkyl of from three to eight carbon atoms, and --NR 5 R 6 where R 5 is selected from the group consisting of hydrogen, alkyl of from one to six carbon atoms, hydroxyalkyl of from one to six carbon atoms, and alkoxyalkyl in which the alkoxy portion and the alkyl portion each contain, independently, from one to six carbon atoms, and R 6 is selected from the group consisting of hydrogen, alkyl of from one to six carbon atoms, hydroxyalkyl of from one to six carbon atoms, alkoxyalkyl in which the alkoxy portion and the alkyl portion each contain, independently, from one to six carbon atoms, alkanoyl of from two to eight carbon atoms, carbocyclic aryl, and (carbocyclic aryl)alkyl in which the alkyl portion contains from one to six carbon atoms.
Claim 2
Dependent Claim
465 words
A compound having the structure ##STR30## or a pharmaceutically acceptable salt thereof wherein A is a valence bond or is a straight or branched divalent alkylene group of from one to twelve carbon atoms; M is selected from the group consisting of hydrogen, a pharmaceutically acceptable cation, and a pharmaceutically acceptable metabolically cleavable group; R 1 is selected from the group consisting of phenoxy, optionally substituted with alkyl of from one to six carbon atoms, haloalkyl of from one to six carbon atoms, alkoxy of from one to six carbon atoms, hydroxy or halogen; phenyl-thio, optionally substituted with alkyl of from one to six carbon atoms, haloalkyl of from one to six carbon atoms, alkoxy of from one to six carbon atoms, hydroxy or halogen; 2-,3-, or 4-pyridyloxy, optionally substituted with alkyl of from one to six carbon atoms, haloalkyl of from one to six carbon atoms, alkoxy of from one to six carbon atoms, hydroxy or halogen; 2-,3-, or 4-pyridylmethoxy, optionally substituted with alkyl of from one to six carbon atoms, haloalkyl of from one to six carbon atoms, alkoxy of from one to six carbon atoms, hydroxy or halogen; 1, or 2-naphthyloxy, optionally substituted with alkyl of from one to six carbon atoms, haloalkyl of from one to six carbon atoms, alkoxy of from one to six carbon atoms, hydroxy or halogen; 2-,4-,5-, or 8-quinolyloxy, optionally substituted with alkyl of from one to six carbon atoms, haloalkyl of from one to six carbon atoms, alkoxy of from one to six carbon atoms, hydroxy or halogen; and 2-,4-,5-, or 8-quinolylmethoxy, optionally substituted with alkyl of from one to six carbon atoms, haloalkyl of from one to six carbon atoms, alkoxy of from one to six carbon atoms, hydroxy or halogen; R 2 and R 3 are independently selected from the group consisting of hydrogen, alkyl of from one to twelve carbon atoms, halogen, and trifluoroalkyl; R 4 is selected from the group consisting of hydrogen, alkyl of from one to twelve carbon atoms, cycloalkyl of from three to eight carbon atoms, and --NR 5 R 6 where R 5 is selected from the group consisting of hydrogen, alkyl of from one to six carbon atoms, hydroxyalkyl of from one to six carbon atoms, and alkoxyalkyl in which the alkoxy portion and the alkyl portion each contain, independently, from one to six carbon atoms, and R 6 is selected from the group consisting of hydrogen, alkyl of from one to six carbon atoms, hydroxyalkyl of from one to six carbon atoms, alkoxyalkyl in which the alkoxy portion and the alkyl portion each contain, independently, from one to six carbon atoms, alkanoyl of from two to eight carbon atoms, carbocyclic aryl, and (carbocyclic aryl)alkyl in which the alkyl portion contains from one to six carbon atoms.
Claim 3
Dependent Claim
35 words
A compound as defined by claim 1 or pharmaceutically acceptable salt thereof wherein R 4 is selected from alkyl of from one to twelve carbon atoms and cycloalkyl of from three to eight carbon atoms.
Claim 4
Dependent Claim
25 words
A compound as defined by claim 1 wherein R 4 is --NR 5 R 6 where R 5 and R 6 are as defined therein.
Claim 5
Dependent Claim
35 words
A compound as defined by claim 3 having the structure ##STR31## wherein A, R 1 , R 2 , R 3 , R 4 , R 5 , and R 6 are as defined therein.
Claim 6
Dependent Claim
12 words
The compound having the name E-N-[4-(5-(4-fluorophenoxy)-2-furanyl)but-3-en-2-yl]-N-hydroxyurea or a pharmaceutically acceptable salt thereof.
Claim 7
Dependent Claim
12 words
The compound having the name E-N-[4-(5-(4-fluorophenoxy)-2-furanyl)but-3-en-2-yl]-N-hydroxyurea or a pharmaceutically acceptable salt thereof.
Claim 8
Dependent Claim
41 words
A compound, or pharmaceutically acceptable salt thereof, selected from the group consisting of E-N-[3-(5-phenoxy-2-furanyl)-2-propen-1-yl]-N-hydroxyurea; Z-N-[4-(5-(4-fluorophenoxy)-2-furanyl)-2-fluorobut-3-en-2-yl]-N-hydroxyurea E-N-[4-(5-phenoxy-2-furanyl)but-3-en-2-yl]-N-hydroxyurea; E-N-[4-(5-(2-fluorophenoxy)-2-furanyl)but-3-en-2-yl]-N-hydroxyurea; E-N-[4-(5-(2,4-difluorophenoxy)-2-furanyl)but-3-en-2-yl]-N-hydroxyurea; E-N-[4-(5-(2-methyl-4-fluorophenoxy)-2-furanyl)but-3-en-2-yl]-N-hydroxyurea; E-N-[4-(5-(4-chlorophenoxy)-2-furanyl)but-3-en-2-yl]-N-hydroxyurea; E-N-[4-(5-(4-bromophenoxy)-2-furanyl)but-3-en-2-yl]-N-hydroxyurea; E-N-[4-(5-(4-n-butoxyphenoxy)-2-furanyl)but-3-en-2-yl]-N-hydroxyurea; E-N-[4-(5-(4-n-butylphenoxy)-2-furanyl)but-3-en-2-yl]-N-hydroxyurea; E-N-[4-(5-(4-thiomethylphenoxy)-2-furanyl)but-3-en-2-yl]-N-hydroxyurea; E-N-[4-(5-(4-cyanophenoxy)-2-furanyl)but-3-en-2-yl]-N-hydroxyurea; E-N-[4-(5-(4-fluorophenoxy)-3-methyl-2-furanyl)but-3-en-2-yl]-N-hydroxyurea; E-N-[4-(5-(2-naphthoxy)-2-furanyl)but-3-en-2-yl]-N-hydroxyurea; E-N-[4-(5-quinolyloxy-2-furanyl)but-3-en-2-yl]-N-hydroxyurea; E-N-[4-(5-(4-fluorothiophenoxy)-2-furanyl)but-3-en-2-yl]-N-hydroxyurea; E-N-[4-(5-(4-thiophenoxy)-2-furanyl)but-3-en-2-yl]-N-hydroxyurea; E-N-[4-(5-(3-pyridnyloxy)but-3-ene-2-yl]-N-hydroxyurea; E-N-[4-(5-(6-methyl-3-pyridnyloxy)-2-furanyl)but-3-en-2-yl]-N-hydroxyurea; E-N-[4-(5-(5-chloro-3-pyridnyloxy)-2-furanyl)but-3-en-2-yl]-N-hydroxyurea; E-N-[4-(5-(2-mercaptopyridinyl)-2-furanyl)but-3-en-2-yl]-N-hydroxyurea; E-N-[4-(5-(4-fluorophenoxy)-2-furanyl)but-3-en-2-yl]-N-hydroxyacetamide; E-N-[3-(5-phenoxy-2-furanyl)-2-propenyl]-N-hydroxyacetamide; E-N-[4-(5-(2,4-difluorophenoxy)-2-furanyl)but-3-en-2-yl]-N-hydroxyacetamide; E-N-[4-(5-(4-n-butoxyphenoxy)-2-furanyl)but-3-en-2-yl]-N-hydroxyacetamide; E-N-[4-(5-(4-fluorothiophenoxy)-2-furanyl)but-3-en-2-yl]-N-hydroxyacetamide; and E-N-4-(5-(3-pyridyloxy)-2-furanyl)but-3-en-2-yl]-N-hydroxyacetamide.
Claim 9
Dependent Claim
41 words
A compound, or pharmaceutically acceptable salt thereof, selected from the group consisting of E-N-[3-(5-phenoxy-2-furanyl)-2-propen-1-yl]-N-hydroxyurea; Z-N-[4-(5-(4-fluorophenoxy)-2-furanyl)-2-fluorobut-3-en-2-yl]-N-hydroxyurea E-N-[4-(5-phenoxy-2-furanyl)but-3-en-2-yl]-N-hydroxyurea; E-N-[4-(5-(2-fluorophenoxy)-2-furanyl)but-3-en-2-yl]-N-hydroxyurea; E-N-[4-(5-(2,4-difluorophenoxy)-2-furanyl)but-3-en-2-yl]-N-hydroxyurea; E-N-[4-(5-(2-methyl-4-fluorophenoxy)-2-furanyl)but-3-en-2-yl]-N-hydroxyurea; E-N-[4-(5-(4-chlorophenoxy)-2-furanyl)but-3-en-2-yl]-N-hydroxyurea; E-N-[4-(5-(4-bromophenoxy)-2-furanyl)but-3-en-2-yl]-N-hydroxyurea; E-N-[4-(5-(4-n-butoxyphenoxy)-2-furanyl)but-3-en-2-yl]-N-hydroxyurea; E-N-[4-(5-(4-n-butylphenoxy)-2-furanyl)but-3-en-2-yl]-N-hydroxyurea; E-N-[4-(5-(4-thiomethylphenoxy)-2-furanyl)but-3-en-2-yl]-N-hydroxyurea; E-N-[4-(5-(4-cyanophenoxy)-2-furanyl)but-3-en-2-yl]-N-hydroxyurea; E-N-[4-(5-(4-fluorophenoxy)-3-methyl-2-furanyl)but-3-en-2-yl]-N-hydroxyurea; E-N-[4-(5-(2-naphthoxy)-2-furanyl)but-3-en-2-yl]-N-hydroxyurea; E-N-[4-(5-quinolyloxy-2-furanyl)but-3-en-2-yl]-N-hydroxyurea; E-N-[4-(5-(4-fluorothiophenoxy)-2-furanyl)but-3-en-2-yl]-N-hydroxyurea; E-N-[4-(5-(4-thiophenoxy)-2-furanyl)but-3-en-2-yl]-N-hydroxyurea; E-N-[4-(5-(3-pyridnyloxy)but-3-ene-2-yl]-N-hydroxyurea; E-N-[4-(5-(6-methyl-3-pyridnyloxy)-2-furanyl)but-3-en-2-yl]-N-hydroxyurea; E-N-[4-(5-(5-chloro-3-pyridnyloxy)-2-furanyl)but-3-en-2-yl]-N-hydroxyurea; E-N-[4-(5-(2-mercaptopyridinyl)-2-furanyl)but-3-en-2-yl]-N-hydroxyurea; E-N-[4-(5-(4-fluorophenoxy)-2-furanyl)but-3-en-2-yl]-N-hydroxyacetamide; E-N-[3-(5-phenoxy-2-furanyl)-2-propenyl]-N-hydroxyacetamide; E-N-[4-(5-(2,4-difluorophenoxy)-2-furanyl)but-3-en-2-yl]-N-hydroxyacetamide; E-N-[4-(5-(4-n-butoxyphenoxy)-2-furanyl)but-3-en-2-yl]-N-hydroxyacetamide; E-N-[4-(5-(4-fluorothiophenoxy)-2-furanyl)but-3-en-2-yl]-N-hydroxyacetamide; and E-N-4-(5-(3-pyridyloxy)-2-furanyl)but-3-en-2-yl]-N-hydroxyacetamide.
Claim 10
Dependent Claim
29 words
A pharmaceutical composition for inhibiting the biosynthesis of leukotrienes comprising a therapeutically effective amount of a compound as defined by claim 1 in combination with a pharmaceutically acceptable carrier.
Claim 11
Dependent Claim
28 words
A method of inhibiting the biosynthesis of leukotrienes comprising administering to a mammal in need of such treatment a therapeutically effective amount of a compound of claim 1.